[1]
|
Lear, J.T. and Smith, A.G. (1997) Basal Cell Carcinoma. Postgraduate Medical Journal, 73, 538-542.
https://doi.org/10.1136/pgmj.73.863.538
|
[2]
|
Lomas, A., Leonardi-Bee, J. and Bath-Hextall, F. (2012) A Systematic Review of Worldwide Incidence of Nonmelanoma Skin Cancer. British Journal of Dermatology, 166, 1069-1080.
https://doi.org/10.1111/j.1365-2133.2012.10830.x
|
[3]
|
Besselink-Lobanova, A., Maandag, N.J.G., Voermans, N.C., et al. (2010) Trachea Rupture in Tenascin-Xdeficient Type Ehlers-Danlos Syndrome. Anesthesiology, 113, 746-749. https://doi.org/10.1111/j.1365-2133.2012.10830.x
|
[4]
|
Wan, C. and Li, Y. (2020) Integrative Analysis of mRNA-miRNA-TFs Reveals the Key Regulatory Connections Involved in Basal Cell Carcinoma. Archives of Dermatological Research, 312, 133-143.
https://doi.org/10.1007/s00403-019-02002-y
|
[5]
|
Ashburner, M., Ball, C.A., Blake, J.A., et al. (2000) Gene Ontology: Tool for the Unification of Biology. The Gene Ontology Consortium. Nature Genetics, 25, 25-29. https://doi.org/10.1038/75556
|
[6]
|
Ogata, H., Goto, S., Sato, K., et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research, 27, 29-34. https://doi.org/10.1093/nar/27.1.29
|
[7]
|
Marzuka, A.G. and Book, S.E. (2015) Basal Cell Carcinoma: Pathogenesis, Epidemiology, Clinical Features, Diagnosis, Histopathology, and Management. The Yale Journal of Biology and Medicine, 88, 167-179.
|
[8]
|
邢天娇, 李东霞. 基底细胞癌诊治的研究进展[J]. 医学综述, 2019(1): 60-64.
|
[9]
|
潘思文, 白云, 阎超, 等. 浅谈Hedgehog信号通路与肿瘤的相关性[J]. 中国药师, 2015(7): 1203-1206.
|
[10]
|
乔琪, 张国惠. 紫外线所致基底细胞癌的分子生物学机制研究进展[J]. 世界最新医学信息文摘, 2019(98): 78-79 + 84.
|
[11]
|
Kim, D.P., Kus, K.J.B. and Ruiz, E. (2019) Basal Cell Carcinoma Review. Hematology/Oncology Clinics of North America, 33, 13-24. https://doi.org/10.1016/j.hoc.2018.09.004
|
[12]
|
Sławińska, M., Zabłotna, M., Gleń, J., et al. (2019) STAT3 Polymorphisms and IL-6 Polymorphism Are Associated with the Risk of Basal Cell Carcinoma in Patients from Northern Poland. Archives of Dermatological Research, 311, 697-704. https://doi.org/10.1007/s00403-019-01952-7
|
[13]
|
Brennan-Crispi, D.M., Overmiller, A.M., Tamayo-Orrego, L., et al. (2019) Overexpression of Desmoglein 2 in a Mouse Model of Gorlin Syndrome Enhances Spontaneous Basal Cell Carcinoma Formation through STAT3-Mediated Gli1 Expression. Journal of Investigative Dermatology, 139, 300-307. https://doi.org/10.1016/j.jid.2018.09.009
|
[14]
|
Taher, M.Y., Davies, D.M. and Maher, J. (2018) The Role of the Interleukin (IL)-6/IL-6 Receptor Axis in Cancer. Biochemical Society Transactions, 46, 1449-1462. https://doi.org/10.1042/BST20180136
|
[15]
|
Heller, E.R., Gor, A., Wang, D., et al. (2013) Molecular Signatures of Basal Cell Carcinoma Susceptibility and Pathogenesis: A Genomic Approach. International Journal of Oncology, 42, 583-596. https://doi.org/10.3892/ijo.2012.1725
|
[16]
|
Ogino, S., Shima, K., Baba, Y., et al. (2009) Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated with Good Prognosis. Gastroenterology, 136, 1242-1250.
https://doi.org/10.1053/j.gastro.2008.12.048
|
[17]
|
Urabe, A., Nakayama, J., Taniguchi, S., et al. (1994) Expression of the fos Oncogene in Basal Cell Carcinoma. Journal of Dermatological Science, 8, 50-53. https://doi.org/10.1016/0923-1811(94)90321-2
|
[18]
|
Lacroix, M. and Body, J.J. (1997) Regulation of c-fos and c-jun Expression by Calcitonin in Human Breast Cancer Cells. Calcified Tissue International, 60, 513-519. https://doi.org/10.1007/s002239900273
|
[19]
|
Strong, A.L., Ohlstein, J.F., Biagas, B.A., et al. (2015) Leptin Produced by Obese Adipose Stromal/Stem Cells Enhances Proliferation and Metastasis of Estrogen Receptor Positive Breast Cancers. Breast Cancer Research, 17, 112.
https://doi.org/10.1186/s13058-015-0622-z
|
[20]
|
Farag, A.G.A., Elnaidany, N.F. and El-Dien, M.M.S. (2016) Immunohistochemical Expression of Leptin in Non Melanoma Skin Cancer. Journal of Clinical and Diagnostic Research, 10, WC08-WC12.
https://doi.org/10.7860/JCDR/2016/19755.8385
|
[21]
|
Sharma, S.D. and Katiyar, S.K. (2010) Leptin Deficiency-Induced Obesity Exacerbates Ultraviolet B Radiation-Induced Cyclooxygenase-2 Expression and Cell Survival Signals in Ultraviolet B-Irradiated Mouse Skin. Toxicology and Applied Pharmacology, 244, 328-335. https://doi.org/10.1016/j.taap.2010.01.010
|
[22]
|
Mukhtar, H. and Elmets, C.A. (1996) Photocarcinogenesis: Mechanisms, Models and Human Health Implications. Photochemistry and Photobiology, 63, 356-357. https://doi.org/10.1111/j.1751-1097.1996.tb03040.x
|
[23]
|
Scott, K.A., Moore, R.J., Arnott, C.H., et al. (2003) An Anti-Tumor Necrosis Factor-α Antibody Inhibits the Development of Experimental Skin Tumors. Molecular Cancer Therapeutics, 2, 445-451.
|
[24]
|
Fang, M., Wee, S.A., Ronski, K., et al. (2007) Evidence of EGR1 as a Differentially Expressed Gene among Proliferative Skin Diseases. Genomic Medicine, 1, 75-85. https://doi.org/10.1007/s11568-007-9010-9
|
[25]
|
Hong, Y.Y., Yu, F.Y., Qu, J.F., et al. (2014) Fibroblasts Regulate Variable Aggressiveness of Syndromic Keratocystic and Non-Syndromic Odontogenic Tumors. Journal of Dental Research, 93, 904-910.
https://doi.org/10.1177/0022034514542108
|
[26]
|
Tallegas, M., Fraitag, S., Binet, A., et al. (2019) Novel KHDRBS1-NTRK3 Rearrangement in a Congenital Pediatric CD34-Positive Skin Tumor: A Case Report. Virchows Archiv, 474, 111-115.
https://doi.org/10.1007/s00428-018-2415-0
|
[27]
|
Yeh, I., Tee, M.K., Botton, T., et al. (2016) NTRK3 Kinase Fusions in Spitz Tumours. Journal of Pathology, 240, 282-290. https://doi.org/10.1002/path.4775
|
[28]
|
Naor, D., Sionov, R.V. and Ish-Shalom, D. (1997) CD44: Structure, Function, and Association with the Malignant Process. Advances in Cancer Research, 71, 241-319. https://doi.org/10.1016/S0065-230X(08)60101-3
|
[29]
|
Liaw, L., Birk, D.E., Ballas, C.B., et al. (1998) Altered Wound Healing in Mice Lacking a Functional Osteopontin Gene (spp1). Journal of Clinical Investigation, 101, 1468-1478. https://doi.org/10.1172/JCI1122
|
[30]
|
Crawford, H.C., Matrisian, L.M. and Liaw, L. (1998) Distinct Roles of Osteopontin in Host Defense Activity and Tumor Survival during Squamous Cell Carcinoma Progression in Vivo. Cancer Research, 58, 5206-5215.
|
[31]
|
Rangel, J., Nosrati, M., Torabian, S., et al. (2008) Osteopontin as a Molecular Prognostic Marker for Melanoma. Cancer, 112, 144-150. https://doi.org/10.1002/cncr.23147
|
[32]
|
Kashani-Sabet, M., Nosrati, M., Miller, J.R., et al. (2017) Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690. Clinical Cancer Research, 23, 6888-6892.
https://doi.org/10.1158/1078-0432.CCR-17-1317
|
[33]
|
Xu, Y., He, B., Pan, Y., et al. (2013) The Roles of ADIPOQ Genetic Variations in Cancer Risk: Evidence from Published Studies. Molecular Biology Reports, 40, 1135-1144. https://doi.org/10.1007/s11033-012-2154-2
|
[34]
|
Tilg, H. and Moschen, A.R. (2006) Adipocytokines: Mediators Linking Adipose Tissue, Inflammation and Immunity. Nature Reviews Immunology, 6, 772-783. https://doi.org/10.1038/nri1937
|